Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2002 1
2003 1
2004 3
2005 6
2006 5
2007 6
2008 13
2009 11
2010 8
2011 9
2012 8
2013 12
2014 6
2015 10
2016 7
2017 10
2018 13
2019 7
2020 11
2021 7
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

129 results
Results by year
Filters applied: . Clear all
Page 1
Nasopharyngeal carcinoma.
Chua MLK, Wee JTS, Hui EP, Chan ATC. Chua MLK, et al. Among authors: hui ep. Lancet. 2016 Mar 5;387(10022):1012-1024. doi: 10.1016/S0140-6736(15)00055-0. Epub 2015 Aug 28. Lancet. 2016. PMID: 26321262 Review.
Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Bossi P, Chan AT, Licitra L, Trama A, Orlandi E, Hui EP, Halámková J, Mattheis S, Baujat B, Hardillo J, Smeele L, van Herpen C, Castro A, Machiels JP; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org; EURACAN. Bossi P, et al. Among authors: hui ep. Ann Oncol. 2021 Apr;32(4):452-465. doi: 10.1016/j.annonc.2020.12.007. Epub 2020 Dec 25. Ann Oncol. 2021. PMID: 33358989 No abstract available.
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742).
Ma BBY, Lim WT, Goh BC, Hui EP, Lo KW, Pettinger A, Foster NR, Riess JW, Agulnik M, Chang AYC, Chopra A, Kish JA, Chung CH, Adkins DR, Cullen KJ, Gitlitz BJ, Lim DW, To KF, Chan KCA, Lo YMD, King AD, Erlichman C, Yin J, Costello BA, Chan ATC. Ma BBY, et al. Among authors: hui ep. J Clin Oncol. 2018 May 10;36(14):1412-1418. doi: 10.1200/JCO.2017.77.0388. Epub 2018 Mar 27. J Clin Oncol. 2018. PMID: 29584545 Free PMC article. Clinical Trial.
Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis.
Blanchard P, Lee A, Marguet S, Leclercq J, Ng WT, Ma J, Chan AT, Huang PY, Benhamou E, Zhu G, Chua DT, Chen Y, Mai HQ, Kwong DL, Cheah SL, Moon J, Tung Y, Chi KH, Fountzilas G, Zhang L, Hui EP, Lu TX, Bourhis J, Pignon JP; MAC-NPC Collaborative Group. Blanchard P, et al. Among authors: hui ep. Lancet Oncol. 2015 Jun;16(6):645-55. doi: 10.1016/S1470-2045(15)70126-9. Epub 2015 May 6. Lancet Oncol. 2015. PMID: 25957714
Analysis of Plasma Epstein-Barr Virus DNA to Screen for Nasopharyngeal Cancer.
Chan KCA, Woo JKS, King A, Zee BCY, Lam WKJ, Chan SL, Chu SWI, Mak C, Tse IOL, Leung SYM, Chan G, Hui EP, Ma BBY, Chiu RWK, Leung SF, van Hasselt AC, Chan ATC, Lo YMD. Chan KCA, et al. Among authors: hui ep. N Engl J Med. 2017 Aug 10;377(6):513-522. doi: 10.1056/NEJMoa1701717. N Engl J Med. 2017. PMID: 28792880 Free article.
Nasopharyngeal carcinoma: an evolving paradigm.
Wong KCW, Hui EP, Lo KW, Lam WKJ, Johnson D, Li L, Tao Q, Chan KCA, To KF, King AD, Ma BBY, Chan ATC. Wong KCW, et al. Among authors: hui ep. Nat Rev Clin Oncol. 2021 Nov;18(11):679-695. doi: 10.1038/s41571-021-00524-x. Epub 2021 Jun 30. Nat Rev Clin Oncol. 2021. PMID: 34194007 Review.
Investigational drugs for nasopharyngeal carcinoma.
Ma BBY, Hui EP, Chan ATC. Ma BBY, et al. Among authors: hui ep. Expert Opin Investig Drugs. 2017 Jun;26(6):677-685. doi: 10.1080/13543784.2017.1324568. Epub 2017 May 8. Expert Opin Investig Drugs. 2017. PMID: 28446055 Review.
Targeting tumor hypoxia in nasopharyngeal carcinoma.
Hong B, Lui VW, Hashiguchi M, Hui EP, Chan AT. Hong B, et al. Among authors: hui ep. Head Neck. 2013 Jan;35(1):133-45. doi: 10.1002/hed.21877. Epub 2011 Nov 22. Head Neck. 2013. PMID: 22106024 Review.
129 results